Lawrence J. Solin, MD

More than 60,000 women are diagnosed annually with ductal carcinoma in situ (DCIS) of the breast, a non-invasive form of breast cancer. A new guideline for DCIS recently published by three leading national cancer organizations now has the potential to reduce unnecessary surgery, improve clinical outcomes after treatment, and reduce the overall costs of care for these women.

Lawrence J. Solin, MD, chair of Radiation Oncology at the Einstein Healthcare Network, was one of the expert physicians involved in developing the new guideline. In endorsing the new guideline as a major advance to aid physicians and to help women with DCIS receive the best care, Dr. Solin said, “The new statement provides important guidance to improve outcomes for patients, while also allowing for physicians to use clinical judgment and flexibility in treating individual patients.” 

Read More

On May 26, 2016, Debra Somers Copit, MD, director of breast imaging for Einstein Healthcare Network, answered your questions about 3D mammography in an online chat. 

Dr. Copit has devoted her career to developing sophisticated technologies to help detect breast cancer in its earliest stages. In 2012, she was honored by Living Beyond Breast Cancer with the Founder’s Award—the organization’s highest honor.

Read More

In medical terms, it's called digital breast tomosynthesis, but it is better known as 3D mammography—and this sophisticated diagnostic tool represents a remarkable development in the early detection of invasive breast cancers. Einstein uses this breast imaging technology at no additional cost to patients, and it was one of the first medical centers in the entire country to do so routinely, starting in 2011.

One additional benefit 3D mammography lies in its lower rates of false positive results. That reduces the need for unnecessary follow-up testing. All told, 3D mammography offers vast benefits compared to the previous 2D screening.

But how does 3D mammography work? Precisely how is it different from 2D? How much more sensitive is this advanced diagnostic and screening tool?

The following interactive infographic explains it all.

Read More

Digital breast tomosynthesis, otherwise known as 3D mammography, represents a striking development in breast cancer detection. Tomosynthesis improves detection of invasive breast cancers and lowers the number of false positive results—thus reducing the need for additional, unnecessary follow-up testing.

Einstein uses 3D mammography, at no extra cost to patients, and was one of the first medical centers in the country to employ the technology, initially as a research tool in 2009 and then routinely on all patients after FDA approval in 2011.

Read More

Q: How long have you worked at Einstein?

A: 20 years.

Q: What does “More than Medicine” mean to you?

A: It means the science of medicine combined with the compassion of medicine and the education of medical students and residents all combined into one.

Q: What gets you excited about coming to work at Einstein?

Read More

Over a lifetime, many women will face concerns about breast health—pain, lumps, nipple discharge, or changes in skin or breast size or shape. Since 1981, the Einstein Breast Health Program has been at the forefront of addressing these concerns.

“We started the conversation more than 30 years ago to learn what women wanted with regard to breast health and the treatment of breast cancer,” says Einstein’s Robert G. Somers, MD, FACS, a pioneer of breast conservation and under whose leadership the program was established.

Today, the Einstein Breast Health Program serves thousands of women annually, providing risk assessment, prevention and screening care, disease diagnosis, treatment and recovery. 

“Einstein has always had a strong presence in the field of breast imaging,” says Debra Somers Copit, MD, FACR, director of Breast Imaging at Einstein Healthcare Network since 1995. “In the 1950s, we were one of only a few institutions in the country to offer mammograms. Back then, the dose of x-ray was too high, and my predecessor, Dr. Isard, worked with physicians at DuPont to develop low-dose mammography. He was deeply involved in bringing mammography into the national and global consciousness.”

Read More

This Mother's Day, hundreds of doctors, nurses, employees, patients, family members and breast cancer survivors from Einstein Healthcare Network will be out in force on the Benjamin Franklin Parkway as Team Einstein supports the 25th Annual Komen Philadelphia Race for the Cure.

To say that Team Einstein is present at the Race is a vast understatement. Among the approximately 100,000 people at the event, one can't help but notice Team Einstein's impressive presence. The team has averaged more than 700 members every year for the past four years.

"In the 25-year history of our Race for the Cure, Team Einstein has had the largest team presence by far," said Elaine I. Grobman, CEO, Susan G. Komen Philadelphia.

In 2011, Komen Philadelphia Race organizers started the "Ultimate Hospital Showdown" to rally local hospitals in support of the Race. Team Einstein embraced the challenge beyond expectations—and every year has taken the Showdown title for the largest team. Moreover, for three of those years, Team Einstein also came in as the top hospital fundraiser.

Read More